Ibogaine and noribogaine: Structural analysis and stability studies. Use of LC-MS to determine alkaloid contents of the root bark of Tabernanthe iboga

Journal of Liquid Chromatography and Related Technologies

Volumn 30, Issue 8, 2007, Pages 1077-1092

  Kontrimaviciute V ^a,b   Mathieu, O ^c   Balas, L ^a   Escale, R ^a   Blayac, Jean Pierre ^c   Bressolle, F M M ^a  

^a UNIV MONTPELLIER   (France)

^b KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^c LAPEYRONIE HOSPITAL   (France)

Author keywords

Alkaloids of Tabernanthe iboga; Ibogaine; IR; LC MS; NMR; Noribogaine; Stability studies

Indexed keywords

ALKALOIDS OF TABERNANTHE IBOGA; ELECTROSPRAY MASS SPECTROMETRY; LIGHT EXPOSURE; ROOT BARK;

LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLANTS (BOTANY); STABILITY; STRUCTURAL ANALYSIS; WOOD PRODUCTS;

NITROGEN COMPOUNDS;

ALKALOID; DESMETHOXYIBOCHINE; DESMETHOXYIBOLUTEINE; DRUG METABOLITE; IBOCHINE; IBOGAINE; IBOGALINE; IBOGAMINE; IBOLUTEINE; INDOLE ALKALOID; METHANOL; NORIBOGAINE; PLANT EXTRACT; TABERNANTHE IBOGA EXTRACT; UNCLASSIFIED DRUG; VOACANGINE;

ARTICLE; CONCENTRATION RESPONSE; DRUG DETERMINATION; DRUG STABILITY; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; LIGHT EXPOSURE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEDICINAL PLANT; OXIDATION; PLANT ROOT; PROTON TRANSPORT; TABERNANTHE IBOGA;

ALKALOIDS; BARK; INFRARED RADIATION; LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE; ROOTS; STABILITY; STRUCTURAL ANALYSIS;

TABERNANTHE IBOGA;

EID: 33847788844     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826070601128451     Document Type: Article

References (20)

1. Obach, R.; Pablo, J.; Mash, D. Cytochrome P4502d6 catalyzes the o-demethylation of the psychoactive alkaloid ibogaine to 12-hydroxyibogamine. Drug Metab. Dispo. 1998, 26, 764-768.
2. Popik, P.; Skolnick, P. Pharmacology of ibogaine and ibogaine-related alkaloids. Alkaloids 1999, 52, 197-231.
3. Xu, Z.; Chang, L.; Slikker, W., Jr.; Ali, S.; Rountree, R.; Scallet, A. A dose-response study of ibogaine induced neuropathology in the rat cerebellum. Toxicol. Sci. 2000, 57, 95-101.
4. Goutarel, R.; Gollnhofer, O.; Sillans, R. Pharmacodynamie et applications therapeutiques de l'iboga et de l'ibogaine [Pharmacodynamics and therapeutic actions of iboga and ibogaine]. Psychedc. Mono. Essays 1993, 6, 71-111.
5. Shulgin, A.; Shulgin, A. TiKHAL: The Continuation (Tryptamines I Have Known and Loved); Transform Press: 1977.
6. Naranjo, C. Psychotherapeutic possibilities: New fantasy enhancing drugs. Clin. Toxicol. 1969, 2, 209-224.
7. Popik, P.; Skolnick, P. Pharmacology of ibogaine and ibogaine-related alkaloids. In The Alkaloids; Cordell, G.A., ed.; Academic Press: San Diego, 1999, 197-231.
8. http://userpages.umbc.edu/~jfreed1/Ibogaine.html assessed 30/03/2006.
9. Mash, D.C.; Kovera, C.A.; Buck, B.E.; Norenberg, M.D.; Shapshak, P.; Hearn, W.L.; Sanchez-Ramos, J. Medication development of ibogaine as a pharmacotherapy for drug dependence. Ann. N.Y. Acad. Sci. 1998, 844, 274-292.
10. Mash, D.C.; Kovera, C.A.; Pablo, J.P.; Tyndale, R.F.; Ervin, F.D.; Williams, I.C.; Singleton, E.G.; Mayor, M. Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures. Ann. N.Y. Acad. Sci. 2000, 914, 394-401.
11. Taylor, W.I. The iboga and Vocanca alkaloids. In The Alkaloids Chemistry and Physiology; Manske, R.H.F., ed.; Academic Press: New York, London, 1965. Vol. VIII, 203-235.
12. Arai, G.; Coppola, J.; Jeffrey, G.A. The structure of ibogaine. Acta Cryst. 1960, 13, 553-64.
13. Wenkert, E.; Cochran, D.W.; Gottlieb, H.E.; Hagaman, E.W. 13C-NMR. Spectroscopy of naturally occurring substances. XLV. Iboga alkaloids. Helv. Chim. Acta 1976, 59, 2437-2442.
14. Kontrimavičiūtė, V.; Breton, H.; Mathieu, O.; Mathieu-Daudé, J.C.; Bressolle, F. Liquid Chromatography-electrospray mass spectrometry determination of ibogaine and 12-hydroxy-ibogamine in human plasma and whole blood. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2006, June 22; [Epub ahead of print].
15. Kontrimavičiūtė, V.; Larroque, M.; Briedis, V.; Margout, D.; Bressolle, F. Quantitation of ibogaine and 12-hydroxy-ibogaine in human plasma by liquid chromatography and solid phase extraction. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2005, 822, 285-93.
16. Clivio, P.; Richard, B.; Deverre, J.R.; Sevenet, T.; Zeches, M.; Le Men-Oliver, L. Alkaloids from leaves and root bark of Ervatamia Hirta. Phytochem. 1991, 30, 3785-3792.
17. Goutarel, M.; Janot, M.M.; Mathys, E.; Prelog, V. Uber das ibolutein. Helv. Chemica Acta 1956, 89, 742-748.
18. Sharma, P.; Cordell, G.A. Heyneanine hydroxyindolenine, a new indole alkaloid from Ervatamia coronaria var. plena. J. Nat. Prod. 1988, 51, 528-531.
19. Kontrimavičiūtė, V.; Mathieu, O.; Mathieu-Daudé, J.C.; Vainauskas, P.; Casper, T.; Baccino, E.; Bressolle, F. Distribution of ibogaine and noribogaine in a man following a poisoning involving root bark of the Tabernanthe Iboga shrub. J. Anal. Toxicol. 2006, 30, 434-440.
20. Jenks, C.W. Extraction studies of Tabernanthe Iboga and Voacanga Africana. Nat. Prod. Lett. 2002, 16, 71-76.